Innovation

Novel Materials for Nucleic Acid, Protein and Drug Delivery

University of Connecticut
posted on 07/24/2010

Biomolecule-containing nanoparticles developed for biomedical applications often suffer the drawbacks of decreased enzyme activity or denaturation, especially under high temperature conditions. Prof. Kumar’s team discovered that biomolecules entrapped in inorganic metal carbonate particles are reversibly denatured upon autoclaving and retain their biological activity even after high temperature treatment. High temperature disinfection with retention of activity is a crucial requirement for use of proteins, enzymes, nucleic acids or peptides in biomedical devices, therapeutic implants or chemical reactors. The size range of the particles is easily controlled from microns to nanometers by adjusting the reaction conditions. Furthermore the encapsulating metal carbonate material is non-toxic to biological systems.

Production of the biomolecule/metal carbonate nanoparticles is inexpensive, non-toxic and can be readily scaled-up to produce large quantities using simple methods. These materials can be useful for cell-free synthesis of proteins, in-vivo synthesis of peptides, delivery systems for biological therapies, and enzyme reactors. Use of these materials in high-temperature applications such as energy conversion, biofuel production or biocatalysis can also be envisioned.

Suggested Uses

-cell-free synthesis of proteins
-in-vivo synthesis of peptides
-delivery systems for biological therapies
-enzyme reactors
-energy conversion
-biofuel production
-biocatalysis

Advantages

This technology allows high-temperature treatments of the biomass without sacrifice their biological activity.


Innovation Details
 

Detailed Description

For more information please contact:
Donna Cyr
860-679-8185
dcyr@uchc.edu

File Number: 09-043 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Donna Cyr at University of Connecticut for more information.

Request more info via email request more info
People

Principal Investigator:

Challa Kumar Challa Kumar

Innovations (1)


Case Manager:

Donna Cyr Donna Cyr

Innovations (20)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...